Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Iovance Biotherapeutics, Inc. (IOVA) since 2015 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Iovance Biotherapeutics, Inc.. Table 2 shows the detailed insider transactions. This company's CIK number is 1425205.
Total stock buying since 2015: $159,601,426.
Total stock sales since 2015: $28,739,625.
Total stock option exercises since 2015: $598,500.
| Insider Buying | Insider Sales | Option Exercises | ||||
|---|---|---|---|---|---|---|
| Year | Shares | Value | Shares | Value | Shares | Value |
| 2025 | 5,600 | $9,744 | 0 | $0 | 675,832 | $0 |
| 2024 | 5,282,000 | $48,330,300 | 50,000 | $503,000 | 406,226 | $372,500 |
| 2023 | 5,010,000 | $26,555,599 | 0 | $0 | 136,769 | $0 |
| 2022 | 11,069,500 | $72,051,657 | 0 | $0 | 97,390 | $226,000 |
| 2018 | 1,243,053 | $12,654,126 | 0 | $0 | 0 | $0 |
| 2016 | 0 | $0 | 54,000 | $491,724 | 0 | $0 |
| 2015 | 0 | $0 | 2,895,682 | $27,744,901 | 40,000 | $0 |
| Trading Period | Insider Buying | Insider Sales | Option Exercises | |||
|---|---|---|---|---|---|---|
| year-month | Shares | Value | Shares | Value | Shares | Value |
| 2025-09 | 0 | $0 | 0 | $0 | 82,559 | $0 |
| 2025-06 | 0 | $0 | 0 | $0 | 91,343 | $0 |
| 2025-05 | 5,600 | $9,744 | 0 | $0 | 0 | $0 |
| 2025-03 | 0 | $0 | 0 | $0 | 475,469 | $0 |
| 2025-01 | 0 | $0 | 0 | $0 | 26,461 | $0 |
| 2024-12 | 0 | $0 | 0 | $0 | 26,173 | $0 |
| 2024-11 | 0 | $0 | 50,000 | $503,000 | 50,000 | $372,500 |
| 2024-10 | 0 | $0 | 0 | $0 | 26,460 | $0 |
| 2024-09 | 0 | $0 | 0 | $0 | 135,029 | $0 |
| 2024-07 | 0 | $0 | 0 | $0 | 26,461 | $0 |
| 2024-06 | 0 | $0 | 0 | $0 | 17,839 | $0 |
| 2024-04 | 0 | $0 | 0 | $0 | 26,458 | $0 |
| 2024-03 | 0 | $0 | 0 | $0 | 71,346 | $0 |
| 2024-02 | 5,282,000 | $48,330,300 | 0 | $0 | 0 | $0 |
| 2024-01 | 0 | $0 | 0 | $0 | 26,460 | $0 |
| 2023-10 | 0 | $0 | 0 | $0 | 26,461 | $0 |
| 2023-09 | 5,010,000 | $26,555,599 | 0 | $0 | 0 | $0 |
| 2023-07 | 0 | $0 | 0 | $0 | 26,460 | $0 |
| 2023-04 | 0 | $0 | 0 | $0 | 26,458 | $0 |
| 2023-01 | 0 | $0 | 0 | $0 | 57,390 | $0 |
| 2022-12 | 10,010,000 | $65,061,500 | 0 | $0 | 0 | $0 |
| 2022-11 | 21,000 | $128,780 | 0 | $0 | 0 | $0 |
| 2022-08 | 0 | $0 | 0 | $0 | 40,000 | $226,000 |
| 2022-06 | 501,000 | $3,221,940 | 0 | $0 | 57,390 | $0 |
| Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2025-09-02 | Puri Raj K. (Chief Regulatory Officer) | Option Ex | 5,470 | .00 | 0 |
| 2025-09-02 | Graf Finckenstein Friedrich (Chief Medical Officer) | Option Ex | 12,697 | .00 | 0 |
| 2025-09-02 | Vogt Frederick G (Interim CEO & General Counsel) | Option Ex | 52,086 | .00 | 0 |
| 2025-09-02 | Bilinsky Igor (Chief Operating Officer) | Option Ex | 12,306 | .00 | 0 |
| 2025-06-02 | Puri Raj K. (Chief Regulatory Officer) | Option Ex | 5,469 | .00 | 0 |
| 2025-06-02 | Graf Finckenstein Friedrich (Chief Medical Officer) | Option Ex | 12,695 | .00 | 0 |
| 2025-06-02 | Bellemin Jean-marc (Chief Financial Officer) | Option Ex | 8,789 | .00 | 0 |
| 2025-06-02 | Vogt Frederick G (Interim CEO & General Counsel) | Option Ex | 52,085 | .00 | 0 |
| 2025-06-02 | Bilinsky Igor (Chief Operating Officer) | Option Ex | 12,305 | .00 | 0 |
| 2025-05-23 | Puri Raj K. (Chief Regulatory Officer) | Buy | 5,600 | 1.74 | 9,744 |
| 2025-03-14 | Puri Raj K. (Chief Regulatory Officer) | Option Ex | 8,334 | .00 | 0 |
| 2025-03-03 | Puri Raj K. (Chief Regulatory Officer) | Option Ex | 59,999 | .00 | 0 |
| 2025-03-03 | Graf Finckenstein Friedrich (Chief Medical Officer) | Option Ex | 62,497 | .00 | 0 |
| 2025-03-03 | Bellemin Jean-marc (Chief Financial Officer) | Option Ex | 58,590 | .00 | 0 |
| 2025-03-03 | Vogt Frederick G (Interim CEO & General Counsel) | Option Ex | 223,943 | .00 | 0 |
| 2025-03-03 | Bilinsky Igor (Chief Operating Officer) | Option Ex | 62,106 | .00 | 0 |
| 2025-01-14 | Graf Finckenstein Friedrich (Chief Medical Officer) | Option Ex | 2,813 | .00 | 0 |
| 2025-01-14 | Vogt Frederick G (Interim CEO & General Counsel) | Option Ex | 20,835 | .00 | 0 |
| 2025-01-14 | Bilinsky Igor (Chief Operating Officer) | Option Ex | 2,813 | .00 | 0 |
| 2024-12-16 | Puri Raj K. (Chief Regulatory Officer) | Option Ex | 8,334 | .00 | 0 |
| 2024-12-02 | Graf Finckenstein Friedrich (Chief Medical Officer) | Option Ex | 3,906 | .00 | 0 |
| 2024-12-02 | Vogt Frederick G (Interim CEO & General Counsel) | Option Ex | 10,417 | .00 | 0 |
| 2024-12-02 | Bilinsky Igor (Chief Operating Officer) | Option Ex | 3,516 | .00 | 0 |
| 2024-11-12 | Maynard Ryan D | Sale | 50,000 | 10.06 | 503,000 |
| 2024-11-12 | Maynard Ryan D | Option Ex | 50,000 | 7.45 | 372,500 |
| 2024-10-14 | Graf Finckenstein Friedrich (Chief Medical Officer) | Option Ex | 2,813 | .00 | 0 |
| 2024-10-14 | Vogt Frederick G (Interim CEO & General Counsel) | Option Ex | 20,834 | .00 | 0 |
| 2024-10-14 | Bilinsky Igor (Chief Operating Officer) | Option Ex | 2,813 | .00 | 0 |
| 2024-09-03 | Graf Finckenstein Friedrich (Chief Medical Officer) | Option Ex | 27,345 | .00 | 0 |
| 2024-09-03 | Bellemin Jean-marc (Chief Financial Officer) | Option Ex | 23,438 | .00 | 0 |
| 2024-09-03 | Vogt Frederick G (Interim CEO & General Counsel) | Option Ex | 57,292 | .00 | 0 |
| 2024-09-03 | Bilinsky Igor (Chief Operating Officer) | Option Ex | 26,954 | .00 | 0 |
| 2024-07-15 | Graf Finckenstein Friedrich (Chief Medical Officer) | Option Ex | 2,813 | .00 | 0 |
| 2024-07-15 | Vogt Frederick G (Interim CEO & General Counsel) | Option Ex | 20,835 | .00 | 0 |
| 2024-07-15 | Bilinsky Igor (Chief Operating Officer) | Option Ex | 2,813 | .00 | 0 |
| 2024-06-03 | Graf Finckenstein Friedrich (Chief Medical Officer) | Option Ex | 3,906 | .00 | 0 |
| 2024-06-03 | Vogt Frederick G (Interim CEO & General Counsel) | Option Ex | 10,417 | .00 | 0 |
| 2024-06-03 | Bilinsky Igor (Chief Operating Officer) | Option Ex | 3,516 | .00 | 0 |
| 2024-04-15 | Graf Finckenstein Friedrich (Chief Medical Officer) | Option Ex | 2,812 | .00 | 0 |
| 2024-04-15 | Vogt Frederick G (Interim CEO & General Counsel) | Option Ex | 20,834 | .00 | 0 |
| 2024-04-15 | Bilinsky Igor (Chief Operating Officer) | Option Ex | 2,812 | .00 | 0 |
| 2024-03-04 | Graf Finckenstein Friedrich (Chief Medical Officer) | Option Ex | 15,623 | .00 | 0 |
| 2024-03-04 | Vogt Frederick G (Interim CEO & General Counsel) | Option Ex | 41,662 | .00 | 0 |
| 2024-03-04 | Bilinsky Igor (Chief Operating Officer) | Option Ex | 14,061 | .00 | 0 |
| 2024-02-20 | Dukes Iain D. | Buy | 32,000 | 9.15 | 292,800 |
| 2024-02-20 | Rothbaum Wayne P. | Buy | 5,000,000 | 9.15 | 45,750,000 |
| 2024-02-20 | Mcpeak Merrill A | Buy | 250,000 | 9.15 | 2,287,500 |
| 2024-01-16 | Graf Finckenstein Friedrich (Chief Medical Officer) | Option Ex | 2,813 | .00 | 0 |
| 2024-01-16 | Vogt Frederick G (Interim CEO & General Counsel) | Option Ex | 20,834 | .00 | 0 |
| 2024-01-16 | Bilinsky Igor (Chief Operating Officer) | Option Ex | 2,813 | .00 | 0 |
| 2023-10-16 | Graf Finckenstein Friedrich (Chief Medical Officer) | Option Ex | 2,813 | .00 | 0 |
| 2023-10-16 | Vogt Frederick G (Interim CEO & General Counsel) | Option Ex | 20,835 | .00 | 0 |
| 2023-10-16 | Bilinsky Igor (Chief Operating Officer) | Option Ex | 2,813 | .00 | 0 |
| 2023-09-18 | Mcpeak Merrill A | Buy | 10,000 | 5.56 | 55,599 |
| 2023-09-15 | Rothbaum Wayne P. | Buy | 5,000,000 | 5.30 | 26,500,000 |
| 2023-07-14 | Graf Finckenstein Friedrich (Chief Medical Officer) | Option Ex | 2,813 | .00 | 0 |
| 2023-07-14 | Vogt Frederick G (Interim CEO & General Counsel) | Option Ex | 20,834 | .00 | 0 |
| 2023-07-14 | Bilinsky Igor (Chief Operating Officer) | Option Ex | 2,813 | .00 | 0 |
| 2023-04-14 | Graf Finckenstein Friedrich (Chief Medical Officer) | Option Ex | 2,812 | .00 | 0 |
| 2023-04-14 | Vogt Frederick G (Interim CEO & General Counsel) | Option Ex | 20,834 | .00 | 0 |
| 2023-04-14 | Bilinsky Igor (Chief Operating Officer) | Option Ex | 2,812 | .00 | 0 |
| 2023-01-03 | Graf Finckenstein Friedrich (Chief Medical Officer) | Option Ex | 19,690 | .00 | 0 |
| 2023-01-03 | Bellemin Jean-marc (Chief Financial Officer) | Option Ex | 18,850 | .00 | 0 |
| 2023-01-03 | Bilinsky Igor (Chief Operating Officer) | Option Ex | 18,850 | .00 | 0 |
| 2022-12-21 | Mcpeak Merrill A | Buy | 10,000 | 6.15 | 61,500 |
| 2022-12-02 | Rothbaum Wayne P. | Buy | 10,000,000 | 6.50 | 65,000,000 |
| 2022-11-28 | Vogt Frederick G (Interim CEO & General Counsel) | Buy | 1,000 | 5.98 | 5,980 |
| 2022-11-28 | Mcpeak Merrill A | Buy | 10,000 | 6.18 | 61,800 |
| 2022-11-23 | Dukes Iain D. | Buy | 10,000 | 6.10 | 61,000 |
| 2022-08-23 | Mcpeak Merrill A | Option Ex | 40,000 | 5.65 | 226,000 |
| 2022-06-14 | Graf Finckenstein Friedrich (Chief Medical Officer) | Option Ex | 19,690 | .00 | 0 |
| 2022-06-14 | Bellemin Jean-marc (Chief Financial Officer) | Option Ex | 18,850 | .00 | 0 |
| 2022-06-14 | Bilinsky Igor (Chief Operating Officer) | Option Ex | 18,850 | .00 | 0 |
| 2022-06-01 | Vogt Frederick G (Interim CEO & General Counsel) | Buy | 1,000 | 6.44 | 6,440 |
| 2022-06-01 | Rothbaum Wayne P. | Buy | 500,000 | 6.43 | 3,215,500 |
| 2022-05-31 | Rothbaum Wayne P. | Buy | 500,000 | 6.77 | 3,384,500 |
| 2022-05-31 | Maynard Ryan D | Buy | 7,500 | 6.75 | 50,587 |
| 2022-05-31 | Weiser Michael | Buy | 10,000 | 6.79 | 67,950 |
| 2022-05-31 | Mcpeak Merrill A | Buy | 20,000 | 6.82 | 136,400 |
| 2018-12-18 | Dukes Iain D. | Buy | 12,000 | 8.65 | 103,800 |
| 2018-12-13 | Mcpeak Merrill A | Buy | 10,000 | 9.63 | 96,270 |
| 2018-12-06 | Rothbaum Wayne P. | Buy | 300,000 | 9.86 | 2,958,000 |
| 2018-12-04 | Rothbaum Wayne P. | Buy | 921,053 | 10.31 | 9,496,056 |
| 2016-08-22 | Hillsberg Sanford (Director) | Sale | 54,000 | 9.11 | 491,724 |
| 2015-09-08 | Hillsberg Sanford (Director) | Sale | 16,500 | 7.13 | 117,645 |
| 2015-09-04 | Hillsberg Sanford (Director) | Sale | 16,000 | 6.84 | 109,440 |
| 2015-08-03 | Hillsberg Sanford (Director) | Sale | 32,500 | 8.15 | 264,875 |
| 2015-05-06 | Hillsberg Sanford (Director) | Sale | 50,000 | 10.00 | 500,000 |
| 2015-05-01 | Acm Capital Partners, Llc | Sale | 2,780,682 | 9.62 | 26,752,941 |
| 2015-02-28 | Hawkins Elma (President and CEO) | Option Ex | 40,000 | .00 | 0 |
Insider trading activities including stock purchases, stock sales, and option exercises of IOVA listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Iovance Biotherapeutics, Inc. (symbol IOVA, CIK number 1425205) see the Securities and Exchange Commission (SEC) website.